| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |